Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Major histocompatibility complex class I H-2K^b^ (H-2K^b^) is a mouse MHC class I molecule composed of a polymorphic heavy α-chain (approximately 350 amino acids) non-covalently associated with the invariant β2-microglobulin light chain (99 amino acids), forming a peptide-binding groove between α1 and α2 domains flanked by α-helices and an eight-stranded β-sheet floor.[1][4][5][8] This groove binds short peptides (typically 8-9 residues) derived from intracellular proteins, such as viral antigens like the vesicular stomatitis virus nucleoprotein (VSV N52-59 octapeptide), positioning them for recognition by cytotoxic CD8+ T-cell receptors (TCRs).[1][2][3][7][9] Crystal structures at 2.8 Å resolution reveal allele-specific architecture that dictates peptide anchor residues and hydrogen bonds, primarily involving main-chain atoms of the peptide with conserved tyrosines (e.g., Tyr-84, Tyr-171) at groove ends, ensuring stable presentation.[1][2][4] H-2K^b^ shares high structural homology with human HLA class I molecules (rms deviation ~1.9 Å for α-chains), supporting conserved functions in adaptive immunity where the peptide-MHC complex interfaces with TCRs for immune surveillance.[1][3][8] In disease contexts, it plays a key role in anti-viral responses and tumor immunosurveillance, though allelic variations influence peptide repertoire and immune evasion in infections or cancer.[1][2][3][8][9] While not a direct small-molecule drug target, its structure informs immunotherapeutic strategies like peptide vaccines or TCR therapies targeting specific alleles.[1][2][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major histocompatibility complex class I H-2K^b^ (H-2K^b^).